Recent legislative actions supporting technology-based economic development include level funding for the Massachusetts Life Sciences Center, funding to support programs of the Minnesota Science and Technology Authority and the expansion of two state programs in support of technology and life sciences companies in New Jersey.
A recent assessment by the National Research Council (NRC) of the National Nanotechnology Initiative's (NNI) Strategy for Nanotechnology-Related Environmental, Health, and Safety Research concluded the NNI's research plan does not provide a clear picture of the potential risks of nanotechnology, nor does the plan include adequate research goals and comprehensive research needs regarding nanotechnology-specific health and safety issues.The NRC's assessment finds the NNI's stra
Energy issues are anticipated to be a central focus of the Obama Administration. Its first budget request, expected in late February for FY 2010, will show if money for R&D will follow that focus. Which states stand to gain most from an increased emphasis on energy research?
The NSF's Federal Funds for Research and Development series illustrates trends in the U.S. government's funding obligations for science and engineering R&D. Federal funding is distributed to government agencies, academic institutions, research centers, state and local governments, nonprofit organizations, as well as private companies.
A new report published by BIO, Battelle and the Biotechnology Institute finds that student achievement in biosciences varies widely between and within states. It also finds that many states lag behind in programmatic efforts to improve bioscience education, even as the life science industry grows in stature as a common priority for TBED initiatives.
Last week the NIH issued a request for comments regarding potential changes to existing federal regulations covering conflicts of interest in the design, conduct, or reporting of NIH-affiliated research. Through an Advanced Notice of Public Rule Making (ANPRM), the regulations include topics such as:
Despite the global growth of the industry over the past few decades, U.S. venture capital remains as concentrated as ever in the Silicon Valley region, and to a lesser extent, Massachusetts.
Gov. Charlie Crist signed Florida's $66.5 billion 2009-10 budget into law last week, providing a mixed bag of funding outcomes for the state's existing economic development programs.
Seven emerging research universities in Texas would receive funding and incentives to help advance their status to nationally-recognized tier one schools following passage of HB 51, awaiting Gov. Rick Perry's signature.
During the last week of the legislative session, Nebraska Gov. Dave Heineman signed two bills into law - one dealing with R&D tax credits and the other authorizing the development of a statewide biotechnology strategic plan.
Over the past few decades, state and local policymakers have approached the task of increasing regional innovative activity from a number of directions. Leaders have deployed plans to increase the amount of available capital, to train entrepreneurs, to attract research-based companies and other strategies to create a thriving innovation economy. A key issue in this pursuit is how to keep the beneficial results of these efforts local.
New evidence suggests that venture capitalists increasingly view international investment as the future of the industry. The 2009 Global Venture Capital Survey, conducted by the National Venture Capital Association (NVCA) and Deloitte, finds that 52 percent of venture capitalists around the world are currently investing outside their home country. Most investors also believe that their involvement with international partners will increase in the near future.
Gov. Deval Patrick announced last week a venture funds competition providing seed money and mentoring to support new business development, adding to a growing number of states seeking to boost entrepreneurial efforts during the economic downturn (see the March 5, 2009 issue of the Digest).
Geographic Concentration Continues as California Share Grows, SSTI's VC Dashboard Shows
With its most recent release of academic research and development expenditures, the NSF has provided insight into the portion of funding that originates from private companies.
Congress has been debating the need to revise U.S. patent law for years, and, while the debate certainly is not over, a significant hurdle was passed last week when the Senate Judiciary Committee voted 15-4 to move S.515, as amended, for full Senate consideration.
Venture capitalists increasingly turn their attention to investment opportunities outside of the U.S., according to several recent industry reports. Though the U.S. continues to dominate the global venture industry, the current economic crisis has negatively affected national fundraising, investment and exits. At the same time, venture investment outside the U.S. reached a record $13.8 billion in 2008, a five percent increase over the previous year. China, India and Israel in particular have made strides in building thriving VC markets.
The National Institutes of Health (NIH) last week published the final version of its guidelines regarding human stem cell research, in part determining which human embryonic stem cells (hESCs) are eligible for research with NIH funding. The final guidelines contain adjustments from the draft version of the guidelines released on April 23 for public comment, from which the NIH received approximately 49,000 statements from advocacy groups, scientists, medical organizations, religious groups, members of Congress, and private citizens.
Three metropolitan areas dominate the U.S. venture capital landscape: San Francisco, Boston and New York. These cities are home to about half of all U.S. venture firms and about half of all U.S. venture-backed companies. Though venture firms have sprung up around the country over the past 25 years, the three cities have maintained, and even expanded, their share of national firms and investment.
SSTI has prepared a table displaying the amount companies spent on R&D in each state from 2003 to 2007, the state's rank in 2007, the percent change over this five-year period, and the rank of that percent change. For the U.S. as a whole, industry-funded R&D was $204 billion in 2003 and rose to $269.3 billion in 2007 - a five-year jump of 32 percent. Note, the amounts in the chart are not indexed to a single year, but reflect values from when the data was released.
The U.S. venture capital industry showed signs of growth during the second quarter of 2009, according to the most recent update from the National Venture Capital Association and PricewaterhouseCoopers Moneytree Report. While the total number of deals remained flat, total dollars invested increased by 15 percent over the first quarter of the year. Much of the growth is the result of increased investment in seed and early-stage companies, which grew 67 percent over the previous quarter in an encouraging sign for entrepreneurs.
Gov. Jim Doyle signed the 2009-11 biennial budget last month, providing funding for university-based research and enhancing tax credits for angel and venture investors supporting high-tech R&D.
In 2007, the federal government dedicated $111.4 billion to R&D, an amount roughly equal to 0.81 percent of the U.S. gross domestic product (GDP), according to a recent report from the National Science Foundation (NSF). While research-intensive states, such as California, Maryland, Massachusetts and Virginia are the leading targets for federal R&D spending, several other states attracted a comparable amount of federal funding relative to their economies between 2002 and 2007.